SCHEMBL19007376

SCHEMBL19007376

COc1cccc(OCCCNC(=O)OC(C)(C)C)c1-c1ccno1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 5/20 0.45
SCN9A Q15858 1/20 0.45
CA12 O43570 2/20 0.43
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
CA9 Q16790 2/20 0.43
BRD4 O60885 1/20 0.42
KCNH2 Q12809 1/20 0.42
AXL P30530 2/20 0.42
AAK1 Q2M2I8 1/20 0.41
PDPK1 O15530 1/20 0.41
CCNB2 O95067 1/20 0.41
PRKCB P05771 1/20 0.41
CDK1 P06493 1/20 0.41
LYN P07948 1/20 0.41
CCNB1 P14635 1/20 0.41
CCNA2 P20248 1/20 0.41
CDK2 P24941 1/20 0.41
GSK3B P49841 1/20 0.41
RPS6KA3 P51812 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29827219 0.88 KCNH2 (0.52) DRD2CA12CA1CA2CA9
SCHEMBL24936185 0.88 KCNH2 (0.52) DRD2CA12CA1CA2CA9
SCHEMBL18955276 0.86 CYP1A2 (0.43) CYP1A2CYP19A1CYP2C9CYP2C19MTNR1A
SCHEMBL24936246 0.83 KCNH2 (0.43) DRD2CA12CA1CA2CA9
SCHEMBL3514820 0.79 MTNR1A (0.61) DRD2SCN9ACA12CA1CA2
SCHEMBL30773715 0.78 DRD2 (0.52) DRD2SCN9ACA12CA1CA2
SCHEMBL1978348 0.77 DRD2 (0.51) DRD2SCN9ACA12CA1CA2
SCHEMBL22642707 0.77 DRD2 (0.51) DRD2SCN9ACA12CA1CA2
SCHEMBL19007838 0.76 KCNH2 (0.51) DRD2SCN9ACA12CA1CA2
SCHEMBL27380365 0.76 DRD2 (0.50) DRD2SCN9ACA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3389660-B1 COMBINATION THERAPY FOR CANCER LILLY CO ELI (US) 2019-10-16 EP disclosed
WO-2017105982-A1 COMBINATION THERAPY FOR CANCER ELI LILLY AND COMPANY (US) 2017-06-22 WO disclosed